← Browse by Condition
Medical Condition

pd parkinson s disease

Total Trials
6
Recruiting Now
6
Trial Phases
Various

ClinicalMetric tracks all active clinical trials for pd parkinson s disease sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — pd parkinson s disease Clinical Trials

How many clinical trials are currently recruiting for pd parkinson s disease?
ClinicalMetric currently tracks 6 actively recruiting clinical trials for pd parkinson s disease, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 6. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for pd parkinson s disease?
pd parkinson s disease research spans multiple clinical trial phases. Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a pd parkinson s disease clinical trial?
Eligibility criteria for pd parkinson s disease trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
Beijing Tiantan Hospital 2 trials
Chang Gung University 2 trials
University of California, San Francisco 2 trials

Recruiting Clinical Trials

NCT05550714
Recruiting
Choice of Anesthesia in Microelectrode Recording Guided Deep Brain Stimulation for Parkinson's Disease
Enrollment
188 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →
NCT06598878
Recruiting
AR Gait Training for Parkinson's Disease
Enrollment
60 pts
Location
Taiwan
Sponsor
Chang Gung University
View Trial →
NCT07682311
Recruiting
Automated Daytime Adaptive Deep Brain Stimulation Parameter Optimization in Patients Implanted With Percept Neurostimulator
Enrollment
40 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT05895019
Recruiting
Effects of Propofol on Brain Function in Patients With Parkinson's Disease
Enrollment
600 pts
Location
China
Sponsor
Beijing Tiantan Hospital
View Trial →
NCT07398157
Recruiting
Simplified, Scalable, 24-hour Adaptive DBS in Parkinson's Disease
Enrollment
24 pts
Location
United States
Sponsor
University of California, San ...
View Trial →
NCT06596187
Recruiting
Differential Assessment of Hypertonia
Enrollment
45 pts
Location
Taiwan
Sponsor
Chang Gung University
View Trial →

Related Conditions

dexmedetomidine (1) desflurane (1) deep brain stimulation (1) sci spinal cord injury (1)
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology